TECNIS PureSee IOL launches in US following FDA approval for cataract surgeryByOphthalmology Times StaffJune 11th 2026
Everest medicines acquires greater china rights to aceclidine presbyopia eye drop (VIZZ)ByOphthalmology Times StaffJune 8th 2026
Study links alcohol consumption to earlier advanced presbyopia in menByOphthalmology Times Staff ReportsJune 2nd 2026
Correcting textile and garment workers’ vision translates to billions for low-income countriesByLynda ChartersApril 28th 2026
Modular, Shape-Changing IOL for Presbyopia Improves Vision at 36 Months, Demonstrates Lasting EffectsByRyan LivingstonApril 15th 2026